Endosomal Escape

Endosomal Escape refers to the process by which therapeutic payloads delivered into cells via endocytosis avoid degradation within endosomes and lysosomes, reaching the cytoplasm or nucleus where biological activity occurs. This step is critical for modalities such as mRNA therapeutics, siRNA, gene editing components, and certain nanoparticle-based delivery systems, as entrapment within endosomes limits functional delivery and reduces therapeutic efficacy.

The pharmaceutical industry focuses on endosomal escape as a major design objective for lipid nanoparticles, polymer carriers, and conjugate delivery systems. Strategies include pH-responsive materials that destabilise endosomal membranes, fusogenic peptides facilitating membrane disruption, and ionisable lipids that enhance release under acidic conditions. Measuring endosomal escape requires specialised assays using fluorescence tracking, functional readouts, or subcellular localisation studies. Improvements in escape efficiency can dramatically reduce required doses and enhance therapeutic indices. As nucleic acid therapeutics expand, endosomal escape engineering continues as a central innovation frontier.